Published in J Hosp Infect on March 01, 1986
Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin. Antimicrob Agents Chemother (1990) 1.10
Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1994) 0.94
Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections. Antimicrob Agents Chemother (1992) 0.87
Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties. J Antibiot (Tokyo) (1978) 3.62
Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics. J Antimicrob Chemother (1983) 2.52
Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol (2012) 2.07
Postoperative pain treatment SIAARTI Recommendations 2010. Short version. Minerva Anestesiol (2010) 1.70
Teicoplanin-resistant coagulase-negative staphylococci. Lancet (1987) 1.69
Rifampicin: a new rifamycin. I. Bacteriological studies. Arzneimittelforschung (1967) 1.54
Unilateral spinal anesthesia or combined sciatic-femoral nerve block for day-case knee arthroscopy. A prospective, randomized comparison. Minerva Anestesiol (2000) 1.49
Relationships between curing of the F episome by rifampin and by acridine orange in Escherichia coli. Antimicrob Agents Chemother (1973) 1.49
Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations. Arzneimittelforschung (1967) 1.45
Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative. J Antibiot (Tokyo) (1981) 1.42
A40926, a new glycopeptide antibiotic with anti-Neisseria activity. Antimicrob Agents Chemother (1987) 1.42
Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic. Antimicrob Agents Chemother (1995) 1.32
Synthesis and biological properties of N63-carboxamides of teicoplanin antibiotics. Structure-activity relationships. J Med Chem (1989) 1.26
Interaction between rifampicin and trimethoprim in vitro and in experimental infections. J Antimicrob Chemother (1977) 1.16
Cardiovascular effects of two different regional anaesthetic techniques for unilateral leg surgery. Acta Anaesthesiol Scand (1998) 1.15
Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VI. Chemical degradation: physico-chemical and biological properties of acid hydrolysis products. J Antibiot (Tokyo) (1984) 1.13
Conditions for immunosuppression by rifampicin. J Infect Dis (1973) 1.13
A-16686, a new antibiotic from Actinoplanes. II. Biological properties. J Antibiot (Tokyo) (1984) 1.13
Rifamycin B diethylamide (rifamide): activity in experimental infections, absorption and elimination in man. Arzneimittelforschung (1965) 1.12
A double-blind comparison of ropivacaine, bupivacaine, and mepivacaine during sciatic and femoral nerve blockade. Anesth Analg (1998) 1.12
Pericardial effusion after cardiac surgery: incidence, site, size, and haemodynamic consequences. Br Heart J (1994) 1.08
Interscalene brachial plexus anaesthesia with 0.5%, 0.75% or 1% ropivacaine: a double-blind comparison with 2% mepivacaine. Br J Anaesth (1999) 1.03
Errors related to different techniques of intraperitoneal injection in mice. Appl Microbiol (1970) 1.02
Pseudomembranous colitis and rifampicin. Lancet (1980) 1.02
Synthesis and biological activity of some derivatives of rifamycin P. J Med Chem (1990) 1.01
Transesophageal echocardiography as predictor of mitral valve repair. J Heart Valve Dis (2001) 0.96
[Diffuse nodular pulmonary amyloidosis]. Riv Anat Patol Oncol (1965) 0.96
In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A). Antimicrob Agents Chemother (1993) 0.96
Studies of binding C3-substitute rifamycins to human and bovine serum albumin. J Antibiot (Tokyo) (1977) 0.93
A new formula for echo-Doppler estimation of right ventricular systolic pressure. J Am Soc Echocardiogr (1994) 0.93
Fentanyl does not improve the nerve block characteristics of axillary brachial plexus anaesthesia performed with ropivacaine. Acta Anaesthesiol Scand (2001) 0.93
Pulmonary function changes after interscalene brachial plexus anesthesia with 0.5% and 0.75% ropivacaine: a double-blinded comparison with 2% mepivacaine. Anesth Analg (1999) 0.92
Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat. Br J Pharmacol (2007) 0.92
Synthesis and relationship between structure and activity of 2-nitroimidazole derivatives. J Med Chem (1969) 0.91
Pharmacological treatment of chronic pain - the need for CHANGE. Curr Med Res Opin (2010) 0.90
[Clinical and parasitological observations on a case of disseminated furuncular myiasis caused by Cordylobia rodhaini in a man in Ethiopia]. Parassitologia (1991) 0.90
Does speed of intrathecal injection affect the distribution of 0.5% hyperbaric bupivacaine? Br J Anaesth (1998) 0.90
New 5-substituted 1-alkyl-2-nitroimidazoles. J Med Chem (1973) 0.89
Regional anaesthesia for outpatient knee arthroscopy: a randomized clinical comparison of two different anaesthetic techniques. Acta Anaesthesiol Scand (2000) 0.89
The mechanism of action of nitro-heterocyclic antimicrobial drugs. Primary target of 1-methyl-2-nitro-5-vinylimidazole is DNA. J Gen Microbiol (1977) 0.89
SIAARTI recommendations for analgo-sedation in intensive care unit. Minerva Anestesiol (2006) 0.88
Hydrazones of 3-formylrifamycin SV. I - Hydrazones with N-amino-N'-substituted piperazines: synthesis, antibacterial activity and other biological properties. Farmaco Sci (1975) 0.88
[Diabetes in the mother and perinatal risk. Reduction of perinatal risk in pregnancy in diabetics by seeking strict metabolic equilibrium of the maternal disease. 479 cases (1963-1975)]. Rev Med Suisse Romande (1977) 0.88
Synthesis and biological activity of some amide derivatives of the lantibiotic actagardine. J Antibiot (Tokyo) (1990) 0.88
Gardimycin, a new antibiotic from Actinoplanes. III. Biological properties. J Antibiot (Tokyo) (1976) 0.87
Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections. Antimicrob Agents Chemother (1992) 0.87
Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vitro and in vivo experiments in the rabbit. Ital Heart J (2000) 0.87
Comparative analysis of the expression of ERBIN and Erb-B2 in normal human skin and cutaneous carcinomas. Br J Dermatol (2005) 0.87
Pleiotropic effects of a rifampicin-resistant mutation in E. coli. Nat New Biol (1973) 0.87
Updating postoperative pain management: from multimodal to context-sensitive treatment. Minerva Anestesiol (2008) 0.87
Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluid. J Antimicrob Chemother (2000) 0.86
Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro. Antimicrob Agents Chemother (1979) 0.86
Does aggregation substance of Enterococcus faecalis contribute to development of endocarditis? Infection (1998) 0.85
Synthesis and antibacterial activity of a series of basic amides of teicoplanin and deglucoteicoplanin with polyamines. J Med Chem (1992) 0.85
Synthesis and biological activity of new 2-nitroimidazole derivatives. J Med Chem (1978) 0.85
Cardiac performance during unilateral lumbar spinal block after crystalloid preload. Can J Anaesth (1997) 0.84
Lecithin cholesterol acyl transferase deficiency: molecular analysis of a mutated allele. Hum Genet (1990) 0.84
Does clonidine 50 microg improve cervical plexus block obtained with ropivacaine 150 mg for carotid endarterectomy? A randomized, double-blinded study. J Clin Anesth (2006) 0.84
Synthesis and biological evaluation of de(acetylglucosaminyl)didehydrodeoxy derivatives of teicoplanin antibodies. J Med Chem (1989) 0.83
Pain after minimally invasive videoassisted and after minimally invasive open thyroidectomy--results of a prospective outcome study. Langenbecks Arch Surg (2007) 0.83
Randomized comparison of remifentanil-propofol with a sciatic-femoral nerve block for out-patient knee arthroscopy. Eur J Anaesthesiol (2002) 0.83
Definition of the transcription initiation site of human plasminogen gene in liver and non hepatic cell lines. Biochem Biophys Res Commun (1990) 0.83
Change Pain: changing the approach to chronic pain. Minerva Med (2011) 0.83
Synthesis and biological activities of some indolo[2,3-c]isoquinoline derivatives. Farmaco Sci (1979) 0.82
In vitro activity of A-16686, a potential antiplaque agent. Antimicrob Agents Chemother (1984) 0.81
Antimicrobial properties of new derivatives of rifamycin SV. Antimicrob Agents Chemother (Bethesda) (1965) 0.81
The effects of the single or multiple injection technique on the onset time of femoral nerve blocks with 0.75% ropivacaine. Anesth Analg (2000) 0.81
Nitric oxide and prostacyclin influence coronary vasomotor tone in perfused rabbit heart and modulate endothelin-1 activity. J Cardiovasc Pharmacol (1993) 0.81
How the left and right sides of the heart, as well as pulmonary venous drainage, adapt to an increasing degree of head-up tilting in hypertrophic cardiomyopathy: differences from the normal heart. J Am Coll Cardiol (2000) 0.80
A40926 aglycone and pseudoaglycones: preparation and biological activity. J Antibiot (Tokyo) (1988) 0.80
Incidence of hypotension and bradycardia during integrated epidural/general anaesthesia. An epidemiologic observational study on 1200 consecutive patients. Italian Study Group on Integrated Anaesthesia. Minerva Anestesiol (1998) 0.79
Minimum local anesthetic volume blocking the femoral nerve in 50% of cases: a double-blinded comparison between 0.5% ropivacaine and 0.5% bupivacaine. Anesth Analg (2001) 0.79
A double-blind study of axillary brachial plexus block by 0.75% ropivacaine or 2% mepivacaine. Eur J Anaesthesiol (1998) 0.79
[PATHOS study on postoperative pain management in Europe: French data]. Ann Fr Anesth Reanim (2008) 0.79
Enhanced hypoxic pulmonary vasoconstriction in hypertension. Circulation (1989) 0.78
Fast-track anaesthesia for laparoscopic cholecystectomy: a prospective, randomized, multicentre, blind comparison of desflurane-remifentanil or sevoflurane-remifentanil. Eur J Anaesthesiol (2006) 0.78
Chrysanthones, a new source of fungal metabolites with potential antitumor and antiangiogenesis properties. Fitoterapia (2003) 0.78
Tumor necrosis factor alpha and glutathione interplay in chronic heart failure. Arch Mal Coeur Vaiss (2005) 0.78
Block distribution and cardiovascular effects of unilateral spinal anaesthesia by 0.5% hyperbaric bupivacaine. A clinical comparison with bilateral spinal block. Minerva Anestesiol (1998) 0.78
Effects of sympathetic blockade on the efficiency of forced-air warming during combined spinal-epidural anesthesia for total hip arthroplasty. J Clin Anesth (1999) 0.77
Exercise echocardiography versus exercise electrocardiography in the diagnosis of coronary artery disease in hypertension. Am J Hypertens (2000) 0.77
Synthesis and biological activity of two metabolites of 1-methyl-5-(1-methylethyl)-2-nitro-1 H-imidazole, an antiprotozoal agent. J Med Chem (1977) 0.77
Determination of selenium in blood serum by proton-induced X-ray emission. Anal Chem (1977) 0.77
Hydrolyzed milk-serum peptides reduce body weight and fat content of dietary obese rats ameliorating their antioxidant status and liver functions. Panminerva Med (2005) 0.76
Gene therapy: The state of the art and future directions. J Appl Biomater Biomech (2010) 0.76
Acute Pain Service and multimodal therapy for postsurgical pain control: evaluation of protocol efficacy. Minerva Anestesiol (2004) 0.76
1-Methyl-2-nitroimidazol-5-yl derivatives. IIIrd communication. Arzneimittelforschung (1977) 0.76
A non steroidal anti-inflammatory drug that stimulates prostaglandin release. Farmaco Sci (1980) 0.76
Synthesis and biological activity of some 2-aminoimidazoles. Arzneimittelforschung (1977) 0.76
Long-term use of K-strophanthin in advanced congestive heart failure due to dilated cardiomyopathy: a double-blind crossover evaluation versus digoxin. Clin Cardiol (1994) 0.76